1. MitchellPS, ParkinRK, KrohEM, FritzBR, WymanSK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513–10518.
2. ParanjapeT, SlackFJ, WeidhaasJB (2009) MicroRNAs: tools for cancer diagnostics. Gut 58: 1546–1554.
3. DengS, CalinGA, CroceCM, CoukosG, ZhangL (2008) Mechanisms of microRNA deregulation in human cancer. Cell Cycle 7: 2643–2646.
4. TehlerD, Hoyland-KroghsboNM, LundAH (2011) The miR-10 microRNA precursor family. RNA Biol 8: 728–734.
5. LundAH (2010) miR-10 in development and cancer. Cell Death Differ 17: 209–214.
6. MansfieldJH, HarfeBD, NissenR, ObenauerJ, SrineelJ, et al. (2004) MicroRNA-responsive ‘sensor’ transgenes uncover Hox-like and other developmentally regulated patterns of vertebrate microRNA expression. Nat Genet 36: 1079–1083.
7. WolteringJM, DurstonAJ (2008) MiR-10 represses HoxB1a and HoxB3a in zebrafish. PLoS One 3: e1396.
8. GarzonR, PichiorriF, PalumboT, IulianoR, CimminoA, et al. (2006) MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci U S A 103: 5078–5083.
9. HanL, WitmerPD, CaseyE, ValleD, SukumarS (2007) DNA methylation regulates MicroRNA expression. Cancer Biol Ther 6: 1284–1288.
10. MaL, Teruya-FeldsteinJ, WeinbergRA (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682–688.
11. GrimsonA, FarhKK, JohnstonWK, Garrett-EngeleP, LimLP, et al. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91–105.
12. BartelDP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215–233.
13. AgirreX, Jimenez-VelascoA, San Jose-EnerizE, GarateL, BandresE, et al. (2008) Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. Mol Cancer Res 6: 1830–1840.
14. WeissFU, MarquesIJ, WolteringJM, VleckenDH, AghdassiA, et al. (2009) Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology 137: 2136–2137, 2136-2145, e2131-2137.
15. MoriartyCH, PursellB, MercurioAM (2010) miR-10b targets Tiam1: implications for Rac activation and carcinoma migration. J Biol Chem 285: 20541–20546.
16. ChaiG, LiuN, MaJ, LiH, OblingerJL, et al. (2010) MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1. Cancer Sci 101: 1997–2004.
17. JemalA, BrayF, CenterMM, FerlayJ, WardE, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69–90.
18. van den BrinkGR, OfferhausGJ (2007) The morphogenetic code and colon cancer development. Cancer Cell 11: 109–117.
19. KinzlerKW, NilbertMC, SuLK, VogelsteinB, BryanTM, et al. (1991) Identification of FAP locus genes from chromosome 5q21. Science 253: 661–665.
20. MiyoshiY, NagaseH, AndoH, HoriiA, IchiiS, et al. (1992) Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1: 229–233.
21. NishishoI, NakamuraY, MiyoshiY, MikiY, AndoH, et al. (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253: 665–669.
22. MarkowitzSD, BertagnolliMM (2009) Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 361: 2449–2460.
23. MarkowitzSD, DawsonDM, WillisJ, WillsonJK (2002) Focus on colon cancer. Cancer Cell 1: 233–236.
24. MonzoM, NavarroA, BandresE, ArtellsR, MorenoI, et al. (2008) Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res 18: 823–833.
25. VoliniaS, CalinGA, LiuCG, AmbsS, CimminoA, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103: 2257–2261.
26. SchwenkF, BaronU, RajewskyK (1995) A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 23: 5080–5081.
27. MoserAR, PitotHC, DoveWF (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247: 322–324.
28. SuLK, KinzlerKW, VogelsteinB, PreisingerAC, MoserAR, et al. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668–670.
29. GouldKA, DietrichWF, BorensteinN, LanderES, DoveWF (1996) Mom1 is a semi-dominant modifier of intestinal adenoma size and multiplicity in Min/+ mice. Genetics 144: 1769–1776.
30. CormierRT, HongKH, HalbergRB, HawkinsTL, RichardsonP, et al. (1997) Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat Genet 17: 88–91.
31. SilvermanKA, KoratkarR, SiracusaLD, BuchbergAM (2002) Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia. Genome Res 12: 88–97.
32. BaranAA, SilvermanKA, ZeskandJ, KoratkarR, PalmerA, et al. (2007) The modifier of Min 2 (Mom2) locus: embryonic lethality of a mutation in the Atp5a1 gene suggests a novel mechanism of polyp suppression. Genome Res 17: 566–576.
33. HurstingSD, SlagaTJ, FischerSM, DiGiovanniJ, PhangJM (1999) Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. J Natl Cancer Inst 91: 215–225.
34. HatziapostolouM, IliopoulosD (2011) Epigenetic aberrations during oncogenesis. Cell Mol Life Sci 68: 1681–1702.
35. FilipowiczW, BhattacharyyaSN, SonenbergN (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102–114.
36. HuntzingerE, IzaurraldeE (2011) Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 12: 99–110.
37. FrankelLB, ChristoffersenNR, JacobsenA, LindowM, KroghA, et al. (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283: 1026–1033.
38. WilsonPA, PlucinskiM (2011) A simple Bayesian estimate of direct RNAi gene regulation events from differential gene expression profiles. BMC Genomics 12: 250.
39. SelbachM, SchwanhausserB, ThierfelderN, FangZ, KhaninR, et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58–63.
40. BaekD, VillenJ, ShinC, CamargoFD, GygiSP, et al. (2008) The impact of microRNAs on protein output. Nature 455: 64–71.
41. IhalinR, LoimarantaV, TenovuoJ (2006) Origin, structure, and biological activities of peroxidases in human saliva. Arch Biochem Biophys 445: 261–268.
42. HamonCB, KlebanoffSJ (1973) A peroxidase-mediated, streptococcus mitis-dependent antimicrobial system in saliva. J Exp Med 137: 438–450.
43. JosephyPD (1996) The role of peroxidase-catalyzed activation of aromatic amines in breast cancer. Mutagenesis 11: 3–7.
44. CavalieriEL, StackDE, DevanesanPD, TodorovicR, DwivedyI, et al. (1997) Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci U S A 94: 10937–10942.
45. Gorlewska-RobertsKM, TeitelCH, LayJOJr, RobertsDW, KadlubarFF (2004) Lactoperoxidase-catalyzed activation of carcinogenic aromatic and heterocyclic amines. Chem Res Toxicol 17: 1659–1666.
46. BoltonJL, ThatcherGR (2008) Potential mechanisms of estrogen quinone carcinogenesis. Chem Res Toxicol 21: 93–101.
47. CavalieriE, ChakravartiD, GuttenplanJ, HartE, IngleJ, et al. (2006) Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta 1766: 63–78.
48. GradyWM, CarethersJM (2008) Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135: 1079–1099.
49. LewisBP, BurgeCB, BartelDP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15–20.
50. BryantA, PalmaCA, JayaswalV, YangYW, LutherborrowM, et al. (2012) miR-10a is aberrantly overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death. Mol Cancer 11: 8.
51. McConnellBB, GhalebAM, NandanMO, YangVW (2007) The diverse functions of Kruppel-like factors 4 and 5 in epithelial biology and pathobiology. Bioessays 29: 549–557.
52. HuR, ZuoY, ZuoL, LiuC, ZhangS, et al. (2011) KLF4 Expression Correlates with the Degree of Differentiation in Colorectal Cancer. Gut Liver 5: 154–159.
53. HornsteinE, ShomronN (2006) Canalization of development by microRNAs. Nat Genet 38 Suppl: S20–24.
54. MiskaEA, Alvarez-SaavedraE, AbbottAL, LauNC, HellmanAB, et al. (2007) Most Caenorhabditis elegans microRNAs are individually not essential for development or viability. PLoS Genet 3: e215.
55. MendellJT, OlsonEN (2012) MicroRNAs in stress signaling and human disease. Cell 148: 1172–1187.
56. ReiterB, MarshallVM, PhilipsSM (1980) The antibiotic activity of the lactoperoxidase-thiocyanate-hydrogen peroxide system in the calf abomasum. Res Vet Sci 28: 116–122.
57. GotheforsL, MarklundS (1975) Lactoperoxidase activity in human milk and in saliva of newborn infants. Infect Immun 11: 1210–1215.
58. LeighJA, FieldTR, WilliamsMR (1990) Two strains of Streptococcus uberis, of differing ability to cause clinical mastitis, differ in their ability to resist some host defence factors. Res Vet Sci 49: 85–87.
59. KimBW, EsworthyRS, HahnMA, PfeiferGP, ChuFF (2012) Expression of lactoperoxidase in differentiated mouse colon epithelial cells. Free Radic Biol Med 52: 1569–1576.
60. FurtmullerPG, JantschkoW, RegelsbergerG, JakopitschC, ArnholdJ, et al. (2002) Reaction of lactoperoxidase compound I with halides and thiocyanate. Biochemistry 41: 11895–11900.
61. LiKM, TodorovicR, DevanesanP, HigginbothamS, KofelerH, et al. (2004) Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis 25: 289–297.
62. ZahidM, KohliE, SaeedM, RoganE, CavalieriE (2006) The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity. Chem Res Toxicol 19: 164–172.
63. SaeedM, RoganE, CavalieriE (2009) Mechanism of metabolic activation and DNA adduct formation by the human carcinogen diethylstilbestrol: the defining link to natural estrogens. Int J Cancer 124: 1276–1284.
64. FernandezSV, RussoIH, RussoJ (2006) Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells. Int J Cancer 118: 1862–1868.
65. LuoG, SantoroIM, McDanielLD, NishijimaI, MillsM, et al. (2000) Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat Genet 26: 424–429.
66. RudolphKL, MillardM, BosenbergMW, DePinhoRA (2001) Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet 28: 155–159.
67. GossKH, RisingerMA, KordichJJ, SanzMM, StraughenJE, et al. (2002) Enhanced tumor formation in mice heterozygous for Blm mutation. Science 297: 2051–2053.
68. MannMB, HodgesCA, BarnesE, VogelH, HassoldTJ, et al. (2005) Defective sister-chromatid cohesion, aneuploidy and cancer predisposition in a mouse model of type II Rothmund-Thomson syndrome. Hum Mol Genet 14: 813–825.
69. DuursmaAM, KeddeM, SchrierM, le SageC, AgamiR (2008) miR-148 targets human DNMT3b protein coding region. RNA 14: 872–877.
70. FormanJJ, Legesse-MillerA, CollerHA (2008) A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci U S A 105: 14879–14884.
71. OromUA, NielsenFC, LundAH (2008) MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 30: 460–471.
72. TayY, ZhangJ, ThomsonAM, LimB, RigoutsosI (2008) MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455: 1124–1128.
73. HafnerM, LandthalerM, BurgerL, KhorshidM, HausserJ, et al. (2010) Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141: 129–141.
74. RobertsAP, LewisAP, JoplingCL (2011) miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components. Nucleic Acids Res 39: 7716–29.
75. XueX, FengT, YaoS, WolfKJ, LiuCG, et al. (2011) Microbiota downregulates dendritic cell expression of miR-10a, which targets IL-12/IL-23p40. J Immunol 187: 5879–5886.
76. ChristoffersenNR, ShalgiR, FrankelLB, LeucciE, LeesM, et al. (2010) p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ 17: 236–245.
77. SmythGK, MichaudJ, ScottHS (2005) Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21: 2067–2075.